The verdict clears the way for Aakash to undertake its rights issue, a move that will dilute BYJU’S stake in Akash from 25.75% to less than 5% Last month, Aakash’s shareholders approved an increase in ...
Inexpensive homegrown tablets - think between US$60 and $200 - abound in India, where the per-capita income, despite the fast-rising economy, remains US$3,700 per year. But the uncrowned king of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results